Daniel Ives is the founder and CEO of Shift Bioscience, an early-stage longevity biotechnology company developing anti-aging drugs based on mitochondrial pathways and a single-cell epigenetics discovery platform.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
